Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 11, Number 7—July 2005
Perspective

Drug-resistant Neisseria gonorrhoeae in Michigan

Kathryn E. Macomber*, Martha S. Boehme*, James T. Rudrik*, Dara Ganoczy†, Erin Crandell-Alden*, William A. Schneider*, and Patricia A. Somsel*
Author affiliations: *Michigan Department of Community Health, Lansing, Michigan, USA; †Department of Veterans Affairs, Ann Arbor, Michigan, USA

Main Article

Table 4

Prevalence of ciprofloxacin-resistant gonorrhea infection among surveillance population

% patients with QRNG (n/total) Prevalence ratio (95% confidence interval) p value
Sex 1.02 (1.00–1.04) 0.03
Male 3 (19/697)
Female 1 (3/375)
Men who have sex with men 1.14 (1.05–1.24) <0.0001
Yes 14 (12/87)
No 1 (7/488)
White 1.07 (1.02–1.11) <0.0001
Yes 7 (13/178)
No 1 (9/896)
Discharge and/or dysuria 0.991 (0.960–1.02) 0.57
Yes 2 (16/724)
No 3 (4/131)
History of gonorrhea 0.991 (0.967–1.02) 0.52
Yes 2 (7/285)
No 3 (14/425)
>40 y of age 1.02 (0.975–1.06) 0.30
Yes 4 (3/84)
No 2 (19/990)

Main Article

Page created: April 24, 2012
Page updated: April 24, 2012
Page reviewed: April 24, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external